Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NOTUM | Q6P988 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | GLA | P06280 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | TP53 | P04637 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | MPI | P34949 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | PKM | P14618 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.36 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30680096 | 0.79 | NOTUM (0.38) | NOTUML3MBTL1GLAKMT2ATP53 | |
| SCHEMBL27159749 | 0.79 | NOTUM (0.38) | NOTUML3MBTL1GLAKMT2ATP53 | |
| SCHEMBL16741104 | 0.75 | PTGDR2 (0.53) | L3MBTL1GLAKMT2ALMNASMN1; SMN2 | |
| SCHEMBL30680090 | 0.75 | PTGDR2 (0.53) | L3MBTL1GLAKMT2ALMNASMN1; SMN2 | |
| SCHEMBL1969238 | 0.74 | USP2 (0.51) | KMT2AMAPTLMNAMEN1SMN1; SMN2 | |
| SCHEMBL30454309 | 0.74 | USP2 (0.51) | KMT2AMAPTLMNAMEN1SMN1; SMN2 | |
| SCHEMBL2547749 | 0.74 | GRM5 (0.49) | L3MBTL1KMT2AMEN1CHRNB2CHRNA4 | |
| SCHEMBL29407668 | 0.74 | GRM5 (0.49) | L3MBTL1KMT2AMEN1CHRNB2CHRNA4 | |
| SCHEMBL15517314 | 0.74 | LMNA (0.53) | L3MBTL1KMT2ATP53MAPTLMNA | |
| SCHEMBL29340719 | 0.72 | NOTUM (0.41) | NOTUML3MBTL1KMT2ATP53MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240239755-A1 | SUBSTITUTED PYRIDAZINONES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | BAYER AKTIENGESELLSCHAFT (DE) | 2024-07-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240239755-A1 | SUBSTITUTED PYRIDAZINONES, SALTS OR N-OXIDES THEREOF AND THEIR USE AS HERBICIDALLY ACTIVE SUBSTANCES | PNPO, WEE1, PDXK | NOTUM 86/4885L3MBTL1 2884/4885GLA 996/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.